OBJECTIVE: To evaluate the impact of moderate body weight loss on both adipose tissue lipoprotein lipase (AT-LPL) activity and expression and to verify whether variation in AT-LPL could be related to changes in lipid ± lipoprotein metabolism. DESIGN: Intervention study of a 15-week weight reducing program (energy de®cit: 500 ± 800 kcalad below the subjects' estimated sedentary energy expenditure). SUBJECTS: Thirty two obese subjects (14 men and 18 premenopausal women; aged 36 ± 50 y) whose body fatness ranged from 34 to 54% fat. MEASUREMENTS: Adipose tissue biopsies from the abdominal and femoral depots, various fatness and fat distribution parameters (computed tomography and anthropometry), fasting plasma concentrations of high-and low-density lipoprotein cholesterol (HDL-C, LDL-C), and triglycerides at baseline and 4 ± 6 weeks after the 15-week weight reducing program, when subjects were weight stable. RESULTS: In response to weight loss, AT-LPL activity of both regions did not change in men, but decreased in women. Regarding AT-LPL expression, no interaction between time and sex was observed in response to the treatment. In both genders, the higher was the basal AT-LPL activity, the greater was the reduction of this enzyme activity in response to weight loss, in both the abdominal and femoral depots ( 7 0.53`r`7 0.84, P values ranging from 0.0001 to 0.05). Body weight loss promoted a signi®cant reduction in plasma triglyceride (TG), insulin and LDL-cholesterol (C) concentrations in men whereas only plasma TG and LDL-C levels were decreased in women (P`0.05). Although the average reduction in HDL-C levels in response to weight loss was not signi®cant, the higher was the decrease in femoral AT-LPL activity, the greater was the reduction in plasma HDL-C levels (r 0.50, P`0.05) in response to weight loss, in women. An inverse relationship was observed between changes in femoral AT-LPL activity and HDL-C levels variation in men (r 7 0.64, P`0.05). CONCLUSION: (1) variation in AT-LPL activity differs between men and women in response to moderate body weight loss although the corresponding enzyme mRNA levels remain unchanged; and (2) changes in femoral AT-LPL activity are related to weight loss induced variation in plasma HDL-C concentrations.
Introduction
Since the pioneering clinical observations of Jean Vague, 1 numerous studies have re-emphasized the notion that men accumulate excess fat predominantly in the abdominal region which represents a health hazard whereas women display a preferential fat deposition in the gluteo-femoral areas which may, at least to a certain extent, be cardioprotective. It is also well known that lipoprotein lipase is involved in the regulation of adipose cell triglyceride storage and, therefore, seems to be a key regulator of fat accumulation in adipose tissue. 2 ± 5 In this regard, regional variation in adipose tissue lipoprotein lipase (AT-LPL) activity has already been hypothesized to account for the gender difference observed in body fat distribution since the enzyme activity is higher in subcutaneous abdominal than in gluteal fat cells in men, whereas the opposite has been observed in premenopausal women. 6 ± 9 However, lipoprotein lipase messenger RNA (mRNA) levels have been reported to be higher in abdominal than in gluteal adipose tissue in both genders. 9 It is also well known that variations in AT-LPL activity occur with changes in body energy balance since the enzyme activity has been reported to increase in the postprandial state, 10, 11 or after a glucose load 10, 12 and to decrease during fasting. 10, 12 Dietary restriction is a strategy commonly used to alter body energy balance and to treat obesity.
Previous studies that have assessed the impact of hypocaloric diet-induced weight loss on AT-LPL activity have reported either a decrease 14 ± 16 or a lack of change 17 in AT-LPL activity, whereas others have observed an increase in the enzyme activity. 18, 19 However, to the best of our knowledge, no study has attempted to compare the potential gender difference in AT-LPL activity as well as in its mRNA level in response to a weight-reducing program. Thus, the aims of the present investigation were: (1) to evaluate the impact of moderate weight loss on both AT-LPL activity and on corresponding mRNA levels in the subcutaneous abdominal and femoral regions in a sample of obese men and premenopausal women; and (2) to verify whether variation in AT-LPL activity and expression could be related to changes in the lipid ± lipoprotein metabolism.
Material and methods

Subjects
Thirty-two obese subjects (14 men and 18 premenopausal women), aged 43 AE 5 y (36 ± 50 y), were recruited through the media and gave their written informed consent to participate in this study, which was approved by the Laval University Medical Ethics Committee. All individuals were subjected to medical evaluation by a physician, which included a medical history. Subjects with cardiovascular disease, diabetes mellitus, endocrine disorders, or those on medication which could have in¯uenced lipid metabolism (bblockers, antihypertensive drugs, etc.) were excluded from the study. All subjects were sedentary, nonsmokers and moderate alcohol consumers. None had recently been on a diet or involved in a weight reducing program, and their body weight had been stable during the last six months prior to the study. Women had regular menstrual cycles and none was using oral contraceptives or lactating at the time of the study. All measurements were performed while women were in the early follicular phase of their menstrual cycle.
All subjects participated in a 15-week weight loss program induced by a moderate caloric restriction which took into account the individual macronutrient composition of subjects' diets, as reported in their 3-d dietary record before experiment (18 ± 19% protein, 38 ± 39% fat, 41 ± 46% carbohydrate and 1 ± 2% alcohol of total energy intake). With the exception of carbohydrate intake which was higher in women than in men (P`0.05), the macronutrient composition was similar in both genders. The energy de®cit determined by the protocol averaged 500 ± 800 kcalad below the subjects' estimated sedentary energy expenditure. This energy de®cit was established according to indirect calorimetry measurements as well as from to estimation of daily energy intake from the 3-d dietary record. Dietary restriction was accompanied by the daily oral intake of 60 mg of fen¯uramine, a serotonin reuptake inhibitor which has been shown to facilitate body weight loss by a hypocaloric diet. 20 Adipose tissue biopsy procedure and adipose tissue lipoprotein lipase (AT-LPL) activity
After an overnight fast, participants were subjected to biopsies of subcutaneous fat, one performed in the periumbilical region (abdominal site) and the other at the anterior midthigh level (femoral site). Local anaesthesia (1% xylocaine, without adrenaline) was performed in such a way that it did not in¯uence the metabolic activity of excised AT. 21 Biopsies were performed before and 4 ± 6 weeks after the end of the treatment when all subjects were weight stable. A small cutaneous incision (1 cm) was performed in both sites and approximately 150 mg of adipose tissue from each region were immediately frozen in liquid nitrogen for later measurement of heparinreleasable LPL activity, according to Savard et al. 22 Brie¯y, duplicates of 20 ± 30 mg adipose tissue were incubated for 40 min at 28 C with 0.5 ml of KrebsRinger-0.1 M Tris-HCl (pH 8.4) containing bovine serum albumin (1 %) and heparin (2.5U) to achieve LPL release from the tissue. The tissue was then removed and 0.5 ml of substrate was added to the released LPL solution which was incubated for 2 h at 28 C under gentle shaking. The substrate consisted of a mixture containing [ 14 C]triolein (1.3mCiaml) and unlabelled triolein (11.1 mgaml) sonicated in gum arabic (5 %) NaCl (2 %) fatty acid free bovine serum albumin (10 %) and fasted human serum. AT-LPL activity was expressed as micromoles of free-fatty acids (FFA) released per h per 10 6 cells (mmol FFAaha10 6 ). Since AT-LPL activity is associated with fat cell size, 3, 22 Another sample of 200 mg adipose tissue was used for the measurement of fat cell size. Adipocytes were isolated according to the method of Rodbell, 23 in a Krebs-Ringer bicarbonate buffer (pH 7.4) containing 4% bovine serum albumin (KRBA) and 5 mM glucose, plus 1 mgaml collagenase, as previously described. 24 Mean adipose cell diameter was assessed from the measurement of at least 500 cells on a microscope equipped with a graduated ocular (Rockleight, NJ), and the density of triolein was used to transform adipose cell volume into fat cell weight, as previously described. 24 Adipose tissue lipoprotein lipase and weight loss P Imbeault et al
RNA preparation
Adipose tissue samples of approximately 50 mg were put in liquid nitrogen and total RNA was isolated using guanidinium thiocyanate phenol chloroform extraction and alcohol precipitation. 25 Due to the limited amount of fat obtained in some subjects, AT-LPL mRNA assays could be only performed on 9 ± 11 men and on 11 ± 13 women for the abdominal and femoral adipose regions, respectively. The average yield of total RNA was 38.1 AE 28.1 and 40.5 AE 26.4 mgag adipose tissue (wet weight) (not signi®cantly different) for biopsies performed before and after treatment, respectively. The absorption ratio (260:280 nm) ranged between 1.6 and 1.9 for all preparations. Total RNA was stored at 7 80 C until quanti®cation of the target mRNA.
Quanti®cation of mRNA
AT-LPL mRNA was quanti®ed by reverse transcription (RT)-polymerase chain reaction (PCR) in the presence of an internal standard, that is, rat adipose tissue, as previously described. 26 Brie¯y, this method is based on the fact that rat and human cDNA segments are homologous to each other, except for 31 bases dispersed throughout the region. 27 There exists a unique BsaJI restriction site in both the rat and human sequences, but they occur in different positions in the two molecules. Therefore, when digested with the BsaJI enzyme (New England Biolabs, Beverly, MA, USA), the human cDNA yields two fragments of equal size for the human cDNA (147 bp), while the rat cDNA yields two fragments of unequal size (136 and 158 bp). The two rat fragments can then be easily separated from each other and from the human fragment when one of the cDNAs is used as an internal standard in the PCR ampli®cation of the other. cDNA was synthesized from 500 ng of total RNA in 20 ml of reverse transcription mixture that had the following ®nal composition: 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 1 mM each of deoxribonucleotides (dNTPs) and 150 pmol of downstream primer (5 H -CTTCACTAGCTGGTCCACAT-3 H ). The tubes were heated at 95 C for 5 min and cooled immediately in ice. 1 ml (200 U) of Moloney murine leukemia virus (M-MLV) reverse transcriptase was added, and the reaction mixture was overlaid with 30 ml of mineral oil. The tubes were incubated at 42 C for 1 h and 95 C for 10 min. The following solutions were added to the reaction tubes on top of the mineral oil: 5 ml of polymerase chain reaction (PCR) buffer (300 mM Tris-HCl, pH 8.3, 200 mM KCl, 13 mM MgCl 2 , 1 mgaml bovine serum albumine, 150 pmol of upstream primer (5
32 P]dCTP, 2 units of Taq DNA polymerase (Boehringer, Mannheim, Canada) and water to a ®nal volume of 50 ml. The samples were heated at 95 C for 3 min and ampli®ed for 30 cycles in a DNA thermal cycler (GeneAmp PCR System 9600, Perkin-Elmer, Norwalk, CT, USA) using the following parameters: 1 min at 94 C, 1 min at 56 C and 1 min at 72 C. Aliquots (30 ml) of PCR products were digested with 2.25 units of the restriction enzyme BsaJI for 2 h at 60 C. The digestion products were separated on a 13.5% polyacrylamide gel, and the bands were revealed by ethidium bromide staining. Radioactivity in the bands were determined by Cherenkov counting after excision from the gel.
Total body fatness and regional fat distribution Body density was determined by the underwater weighing technique and percent body fat was derived from body density. 28 Pulmonary residual volume was measured using the helium dilution method. 29 Fat mass was calculated as total body weight minus fatfree mass. Waist girth was measured according to the procedures recommended at the Airlie Conference. 30 Computed tomography (CT) was performed on a Siemens Somatom DRH scanner (Erlangen, Germany), according to the methodology of Sjo Èstro Èm et al. 31 Brie¯y, subjects were examined in the supine position with both arms stretched above their head. CT scans were performed at both the abdominal (between L4 and L5 vertebrae) and femoral (midthigh) levels, using a radiograph of the skeleton as a reference to establish the position of the scans to the nearest millimetre. Total adipose tissue (AT) areas were calculated by delineating these areas with a graph pen and then computing the AT surfaces with an attenuation range of 7 190 to 7 30 Houns®eld units (HU), 31 as previously described. 32 Abdominal visceral AT area was measured by drawing a line within the muscle wall surrounding the abdominal cavity. The abdominal subcutaneous AT area was calculated by subtracting the visceral AT area from the total abdominal AT area.
Plasma determinations
Blood samples were obtained from an antecubital vein in the morning after a 12-h fast. Fasting plasma glucose and FFA concentrations were measured enzymatically, 33, 34 whereas plasma insulin concentration was determined by radioimmunoassay with polyethylene glycol separation. 35 Cholesterol (C) and triglyceride (TG) concentrations in plasma and lipoprotein fractions were measured enzymatically on a RA-1000 automated analyzer (Technicon Instruments Corporation, Tarrytown, NY, USA). Following ultracentrifugation, the plasma high density lipoprotein (HDL) fraction was obtained after precipitation of low density lipoprotein (LDL) in the infranatant (d b 1.006 gaml) with heparin and MnCl 2 .
36 Plasma LDL-apolipoprotein (apo) B levels were measured by the rocket immunoelectrophoretic method of Laurell, as previously described. 37 Adipose
Statistical analyses
Gender variations were tested for signi®cance with the Student's t-test. The difference between values obtained before and after weight loss was analyzed with a paired t-test. A two-way analysis of variance was also performed to verify whether signi®cant sex and site differences for AT-LPL activity existed before and after weight loss and post hoc comparisons were tested with a paired t-test. Finally, univariate associations between variables were quanti®ed using Pearson's product moment correlation coef®cients. All analyses were performed using the Jump program (SAS Institute Inc., Cary, NC) adapted for Macintosh computers.
Results
Subjects' characteristics
The subjects' physical characteristics before and after the weight-reducing program are presented in Table 1 . Before weight loss, gender comparisons revealed that subcutaneous adipose tissue areas were higher in women than in men (P values ranging from 0.0001 to 0.05), whereas visceral fat accumulation was greater in the latter than in the former subjects (P`0.001). On the other hand, women had larger femoral adipose cells than men (P`0.001), whereas no sex difference was found in subcutaneous abdominal fat cell weight.
As expected, total adiposity was reduced after weight loss, in both genders (P values ranging from 0.0001 to 0.001). Weight reduction was also accompanied by a signi®cant decrease of all the adipose tissue areas and subcutaneous fat cell weights (P values ranging from 0.0001 to 0.05).
The mean weight loss achieved was 10AE 4 kg (range 7 4 to 7 17 kg) vs 9 AE 6 kg (range 0 to 7 23 kg) in men vs women, respectively. Men displayed a greater decrease in fat mass, percent fat and waist girth (P values ranging from 0.001 to 0.05), and a lower reduction in their fat-free mass as compared to women (P`0.001). Finally, subcutaneous abdominal and visceral adipose tissue areas, as well as regional fat cell weight, decreased similarly in response to weight loss, in both genders. Table 2 shows the metabolic pro®le of both men and women, before and after weight loss. At baseline, gender comparisons revealed that men displayed lower plasma HDL-C concentrations compared to women (P`0.05), whereas no sex difference was observed in plasma glucose and insulin concentrations. Plasma TG, LDL-C, LDL-apo B concentrations and insulin concentrations were reduced in men after weight loss (P values ranging from 0.01 to 0.05). Plasma HDL-C tended to be lower in men after weight reduction, although this difference did not reach statistical signi®cance (P 0.06). In women, fasting plasma TG and LDL-C concentrations decreased in AT-LPL activity and expression Figure 1 illustrates the effect of weight reduction on AT-LPL activity expressed either per adipose tissue mass (A), per cell number (B) or corrected for variation in adipocyte surface area (C), in subcutaneous abdominal and femoral adipose regions of both men and women. Before weight loss, no regional variation was found in AT-LPL activity in men, whereas the enzyme activity was higher in the femoral than in the subcutaneous abdominal fat depot in women (P`0.05). Moreover, women displayed a greater pre-weight loss AT-LPL activity in both depots than men (P`0.001). In response to the treatment, a signi®cant time and sex interaction was observed for AT-LPL activity, regardless of the mode of expression of the data and the region studied (F values ranging from 5.4 to 6.7; P values ranging from 0.01 to 0.05). This observation was probably due to the lack of variation in AT-LPL activity in men and to the decrease of the enzyme activity in women. Femoral AT-LPL activity was signi®cantly higher in women than in men, after weight loss (P`0.01). Figure 2 shows the effect of weight loss on AT-LPL expression. No regional variation was observed in AT-LPL mRNA levels before and after weight loss in both genders. On the other hand, women presented higher pre-weight loss subcutaneous abdominal AT-LPL mRNA levels as compared to men (P`0.05). AT-LPL mRNA levels of both subcutaneous abdominal and femoral depots did not change in response to weight loss, in men and women. However, women displayed greater femoral AT-LPL mRNA levels than men at the end of the treatment (P 0.05).
Subjects' metabolic pro®le
Relationships between AT-LPL activity and mRNA levels
The extent of the fall in LPL activity observed after weight reduction in either the subcutaneous abdominal or the femoral fat depot was associated with the initial level of enzyme activity. Indeed, the higher was the pre-weight loss AT-LPL activity measured in both adipose regions, the greater was the reduction of the enzyme activity when expressed per cell surface area in both men ( 7 0.53`r`7 0.71, P values ranging from 0.01 to 0.05) and women ( 7 0.84`r 7 0.87, P values ranging from 0.0001 to 0.001) (Figure 3) . Similar results were observed regardless of the mode of expression of AT-LPL activity, that is, results being expressed per cell number or per adipose tissue mass ( 7 0.53`r`7 0.84, P values ranging from 0.0001 to 0.05) (not shown). Moreover, mRNA level was not signi®cantly correlated with the enzyme activity, irrespective of the gender or the adipose depot ( 7 0.14`r`0.29; not shown).
Furthermore, to verify whether the changes observed in the subjects' metabolic pro®le could be associated with variation in AT-LPL activity or expression, correlational analyses have also been performed. 
Relationships between AT-LPL activity or expression vs metabolic variables
Plasma LDL-C and HDL-C concentrations were the only variables out of the subjects' metabolic pro®le which were associated with AT-LPL activity variation. Indeed, a decrease in subcutaneous abdominal AT-LPL activity was related to a smaller reduction of plasma LDL-C in men (r 7 0.55, P`0.05), whereas no signi®cant association was observed between the latter variables in women (not shown). However, men who were characterized by a decreased femoral AT-LPL activity after weight loss displayed a smaller reduction of plasma HDL-C (r 7 0.64, P`0.05) (Figure 4) . In contrast, the higher was the decrease in femoral AT-LPL activity, the greater was the reduction in plasma HDL-C in women (r 0.50, P`0.05) (Figure 4 ).
Discussion
The present investigation was conducted (1) to examine the effects of a 15-week dietary restriction period on both AT-LPL activity and expression in subcutaneous abdominal and femoral fat depots of men and women, and (2) to verify whether variation in AT-LPL function could be associated with a more favourable or deleterious metabolic pro®le. To the best of our knowledge, our study is the ®rst to investigate the gender variation in the impact of moderate weight loss on LPL activity and its gene expression. Our results show that the enzyme activity does not respond similarly in both genders after weight loss. Indeed, AT-LPL activity of both regions remained unchanged in men, whereas the enzyme activity decreased in both adipose sites from women. This marked gender difference was, however, not observed for AT-LPL mRNA levels in response to the weight-reducing program.
The fact that premenopausal women displayed a higher AT-LPL activity in the femoral than in the subcutaneous abdominal region (Figure 1 ) has already been reported by us 38, 39 and others. 6, 8, 9 The ®nding that men had a similar AT-LPL activity in both adipose depots (Figure 1 ) is also in agreement with previous studies. 7 ± 9,39 Moreover, our data support the notion that both subcutaneous abdominal and femoral AT-LPL activities are higher in women than in men, as previously reported. 8,9,39 ± 41 This sex related difference in AT-LPL activity could be potentially in¯u-enced by variation in steroid hormones. 4, 42 Indeed, progesterone has already been reported to promote the ®lling of gluteo-femoral adipocytes by stimulating LPL activity in these cells, 43 whereas testosterone administered to men has been shown to inhibit LPL in the subcutaneous abdominal but not in the femoral adipose tissue. 44 We also found a signi®cant gender effect on AT-LPL activity in response to weight reduction since Figure 3 Relationships between the changes in AT-LPL activity induced by weight loss and the pre-weight loss enzyme activity in subcutaneous abdominal and femoral regions of men and women. Figure 4 Relationships between the changes in plasma HDL-C concentration and the AT-LPL activity variation following weight loss in subcutaneous abdominal and femoral regions of men and women.
Adipose tissue lipoprotein lipase and weight loss P Imbeault et al AT-LPL activity did not change in men, whereas it decreased in women. Our ®ndings in women, but not in men, are concordant with previous observations. 7, 15, 16 Indeed, one study exclusively composed of men 18 and another that included six men and three women 19 have already reported an increase in AT-LPL activity after weight loss. It is possible that such discrepancy could be due to the substantial mean weight loss (16 and 43 kg) reported in the two previous studies, as already hypothesized. 18, 19 Rebuffe Â-Scrive et al 14 have also proposed several hypotheses to explain this discrepancy such as differences in gender and in the subjects' fatness, as well as the nature and duration of the restrictive diet used to promote weight loss. Up to now, the gender difference observed in AT-LPL activity following weight reduction in the present study cannot be easily explained by available literature, although steroid hormones have been shown to vary between men and women who were subjected to weight loss. 45 Although all these factors may have potentially affected the predicted AT-LPL response to weight loss, the positive relationship observed between the fall in LPL activity and the pre-weight loss enzyme activity (Figure 3 ) is commonly observed among studies reporting a decreased AT-LPL activity.
14 ± 16 However, further studies are clearly warranted to clarify this issue.
A previous study showed that AT-LPL mRNA levels were higher in the abdominal than in the gluteal site of both lean men and women. 9 However, the fact that we did not observe any regional variation in LPL mRNA abundance in both sexes could be partly explained by our subjects' fatness. Amer et al 9 also reported that in both regions, AT-LPL mRNA levels were signi®cantly higher in women than in men. Our results revealed that pre-weight loss AT-LPL mRNA content was higher in the abdominal region of women as compared to men. On the other hand, Kern et al 19 have already reported an increase in the AT-LPL mRNA levels of the abdominal region following a substantial weight loss in massively obese individuals. In our study, no signi®cant variation in AT-LPL expression was observed following the treatment, in either region or gender. This discrepancy could, once again, be explained by the difference in the magnitude of weight lost before subjects stabilized their body weight or by the subjects' level of fatness itself. In the present study, both AT-LPL activity and expression did not change in men whereas the enzyme activity, but not its corresponding mRNA level, decreased following weight reduction in women. Even though we did not measure the lipoprotein lipase mass, it is likely that weight loss induced a decrease AT-LPL activity of women through postranslational mechanisms, as already documented. 9, 11, 46 Finally, it is well known that a substantial part of HDL is derived from surface constituents of chylomicrons and VLDL during breakdown of their triglycerides by lipoprotein lipase. 47, 48 In this regard, Magill et al 49 have already observed that a high gluteal AT-LPL activity increased the fractional rate of catabolism of VLDL, which, in turn, raised HDL-C concentrations. Our results show that a reduced femoral AT-LPL activity is associated with decreased plasma HDL-C concentrations in women. Since a high femoral AT-LPL activity has been reported to be a signi®cant correlate of the more favourable plasma lipoprotein ± lipid pro®le (HDL-C) observed in premenopausal women, 39 a reduced enzyme activity could have an undesirable impact on HDL-C concentrations. St-Amand et al 39 have recently reported that plasma LDL-C concentrations were negatively related to plasma postheparin LPL activity in men, but not to subcutaneous abdominal AT-LPL activity. Although we did not observe any relationship between plasma LDL-C and subcutaneous abdominal AT-LPL activity before weight loss, changes in subcutaneous abdominal AT-LPL activity were signi®cantly associated with LDL-C variation following weight loss, in men. These results could be partly explained by the role of LPL in the retention of LDL in the subendothelial matrix. 50 
Conclusion
This study documents for the ®rst time that variation in AT-LPL activity of both subcutaneous abdominal and femoral regions differs according to gender, even though the magnitude of weight loss is similar in both men and women. However, this sexual dimorphism was not observed at the mRNA level. Variation in AT-LPL activity is not a good predictor of changes occurring in adipose cell size and regional fat during dietary weight reducing therapy. Finally, a reduction in femoral AT-LPL activity following a moderate weight loss through dietary restriction does not appear to preserve the favourable plasma lipoprotein pro®le against the risk of developing coronary heart disease observed in premenopausal women.
